Follow
Thomas Bukur
Thomas Bukur
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma
JC Castle, M Loewer, S Boegel, J de Graaf, C Bender, AD Tadmor, ...
BMC genomics 15, 1-12, 2014
3772014
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
K Reinhard, B Rengstl, P Oehm, K Michel, A Billmeier, N Hayduk, O Klein, ...
Science 367 (6476), 446-453, 2020
3222020
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
C Krienke, L Kolb, E Diken, M Streuber, S Kirchhoff, T Bukur, ...
Science 371 (6525), 145-153, 2021
2962021
HLA typing from RNA-Seq sequence reads
S Boegel, M Löwer, M Schäfer, T Bukur, J De Graaf, V Boisguérin, ...
Genome medicine 4, 1-12, 2013
2892013
Multi-omics characterization of the 4T1 murine mammary gland tumor model
B Schrörs, S Boegel, C Albrecht, T Bukur, V Bukur, C Holtsträter, C Ritzel, ...
Frontiers in oncology 10, 1195, 2020
1402020
HLA and proteasome expression body map
S Boegel, M Löwer, T Bukur, P Sorn, JC Castle, U Sahin
BMC medical genomics 11, 1-12, 2018
1132018
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines
S Boegel, M Löwer, T Bukur, U Sahin, JC Castle
Oncoimmunology 3 (8), e954893, 2014
1112014
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression
J Scholtalbers, S Boegel, T Bukur, M Byl, S Goerges, P Sorn, M Loewer, ...
Genome medicine 7, 1-7, 2015
682015
HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory
C Grunwitz, N Salomon, F Vascotto, A Selmi, T Bukur, M Diken, S Kreiter, ...
Oncoimmunology 8 (9), e1629259, 2019
652019
Cell contact–dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine response
P Bartholomaeus, LY Semmler, T Bukur, V Boisguerin, PS Roemer, ...
The Journal of Immunology 192 (5), 2091-2098, 2014
642014
A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice
N Salomon, F Vascotto, A Selmi, M Vormehr, J Quinkhardt, T Bukur, ...
Oncoimmunology 9 (1), 1771925, 2020
372020
Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates
B Schrörs, P Riesgo-Ferreiro, P Sorn, R Gudimella, T Bukur, T Rösler, ...
PLoS One 16 (9), e0249254, 2021
362021
Bioinformatics for cancer immunotherapy
C Holtsträter, B Schrörs, T Bukur, M Löwer
Bioinformatics for Cancer Immunotherapy: Methods and Protocols, 1-9, 2020
312020
Traveling salesman problem with clustering
JJ Schneider, T Bukur, A Krause
Journal of Statistical Physics 141, 767-784, 2010
142010
Tumor antigens for determining cancer therapy
U Sahin, C Paret, K Vormbrock, C Bender, P Simon, C Hartmann, ...
US Patent 10,188,712, 2019
102019
HLA typing from RNA-seq sequence reads. Genome Med 4: 102
S Boegel, M Löwer, M Schäfer, T Bukur, J de Graaf, V Boisguerin, ...
92012
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. Oncoimmunology 3: e954893
S Boegel, M Lower, T Bukur, U Sahin, JC Castle
82014
In silico typing of classical and non-classical HLA alleles from standard RNA-Seq reads
S Boegel, T Bukur, JC Castle, U Sahin
HLA Typing: Methods and Protocols, 177-191, 2018
72018
Positive role of the MHC class-I antigen presentation regulator m04/gp34 of murine cytomegalovirus in antiviral protection by CD8 T cells
S Becker, A Fink, J Podlech, I Giese, JK Schmiedeke, T Bukur, ...
Frontiers in Cellular and Infection Microbiology 10, 454, 2020
62020
CoVigator—A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants
T Bukur, P Riesgo-Ferreiro, P Sorn, R Gudimella, J Hausmann, T Rösler, ...
Viruses 15 (6), 1391, 2023
42023
The system can't perform the operation now. Try again later.
Articles 1–20